TagsHangzhou HEDA Biological Medicine Venture Capital Partnership

Hangzhou HEDA Biological Medicine Venture Capital Partnership

China

Lynk Pharmaceuticals Closes $50M Series B Financing

FinSMEs - August 29, 2021

THE DAILY NEWSLETTER - SIGNUP

Most Read

“Blockchain Gaming” Documentary Explores Indie Game Development in Web3 and the Polkadot Ecosystem

January 11, 2025

Practical Applications of AI in Everyday Business Solutions

January 10, 2025

Ouro Medicines Raises $120M in Series A Funding

January 10, 2025

Bing Ventures Nominated for Crypto Venture Capital Project Portfolio

January 10, 2025